Hemafer-S

Hemafer‑S is a prescription‑only intravenous solution containing iron as its active ingredient. Formulated for the European market, this iron supplement is supplied as an injectable solution with an unspecified elemental iron strength. It belongs to the drug class of iron supplements and is used to address iron deficiency anemia by providing elemental iron to support hemoglobin synthesis and replenish body iron stores in clinical practice for patients.

Hemafer‑S is indicated for the treatment of iron deficiency anemia in patients who require rapid repletion of iron stores.

- Adults with documented iron deficiency anemia who cannot tolerate oral iron. - Patients undergoing surgery with anticipated blood loss. - Individuals with chronic kidney disease receiving dialysis. - Pregnant women with confirmed iron deficiency when oral therapy is ineffective. - Patients with inflammatory bowel disease associated anemia.

The safety profile of Hemafer‑S includes both frequently observed and less common adverse reactions that may occur after intravenous administration.

Common: - Transient headache or dizziness. - Nausea or mild vomiting. - Injection site discomfort or erythema. - Temporary metallic taste in the mouth.

Serious: - Severe hypersensitivity reactions including anaphylaxis. - Acute hypotension or cardiovascular collapse. - Iron overload leading to organ dysfunction.

Clinicians should consider several precautionary measures before prescribing Hemafer‑S to ensure patient safety and optimal therapeutic outcome.

- Assess baseline hemoglobin, ferritin, and transferrin saturation levels. - Avoid use in patients with known hypersensitivity to iron preparations. - Monitor vital signs during and after infusion for signs of hypotension. - Adjust dose in patients with hepatic or renal impairment. - Use caution in individuals with active infections or inflammatory conditions. - Ensure appropriate iron repletion targets to prevent overload.

Intravenous iron can interact with certain medications and substances, requiring attention to avoid reduced efficacy or increased risk.

Avoid: - Concurrent administration of high‑dose vitamin C or ascorbic acid, which may increase free iron. - Use with other parenteral iron products due to cumulative iron load.

Use with caution: - Antimicrobial agents such as tetracyclines, which may chelate iron and reduce absorption. - Loop diuretics, as rapid iron infusion can affect fluid balance. - Anticoagulants, because infusion‑related hypotension may enhance bleeding risk.